| 1 |
22877244 | Low-level HIV infection of hepatocytes. | 2012 Aug 9 |
1 |
| 2 |
12616665 | Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children. | 2003 Feb |
1 |
| 3 |
12602459 | Relationship between exposure to zidovudine and decrease of P24 antigenemia in HIV-infected patients in monotherapy. | 2002 Oct |
2 |
| 4 |
11563099 | A new class of anti-HIV-1 oligonucleotide targeted to the polypurine tract of viral RNA. | 2001 Apr-Jul |
1 |
| 5 |
11785387 | [Chronically HIV-1 infected human monocyte culture U937 as a model for assessing the efficacy of anti-HIV agents]. | 2001 Nov-Dec |
1 |
| 6 |
11227992 | Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitro. | 2000 Nov |
1 |
| 7 |
10748552 | Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion. | 1999 Jun |
1 |
| 8 |
9468366 | Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects. Community HIV Research Network Investigators. | 1998 Jan 22 |
2 |
| 9 |
9660364 | Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. | 1998 Jul 1 |
2 |
| 10 |
9870320 | Effect of ribavirin on zidovudine efficacy and toxicity in vitro: a concentration-dependent interaction. | 1998 Dec 20 |
2 |
| 11 |
11322271 | Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study. | 1997 Jul |
2 |
| 12 |
11322281 | Viraemia and p24 antigenaemia are independent risk factors for the emergency of a zidovudine-resistant genotype in nucleoside analogue-treated HIV-1 infection. | 1997 Apr |
1 |
| 13 |
8780818 | A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group. | 1996 Jun |
2 |
| 14 |
8816219 | Very late presentation of vertically transmitted HIV-1 infection. | 1996 Jun |
1 |
| 15 |
8817161 | Rate of development of mutation at codon 215 of HIV-1 reverse transcriptase and its predictive factors at the time of initiation of zidovudine therapy. | 1996 Jun |
1 |
| 16 |
7530585 | Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. | 1995 Feb 1 |
2 |
| 17 |
7552477 | Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared. | 1995 Oct 1 |
2 |
| 18 |
7614775 | Zalcitabine. Clinical pharmacokinetics and efficacy. | 1995 May |
1 |
| 19 |
7614899 | Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC). | 1995 |
2 |
| 20 |
7632462 | Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS. | 1995 Apr |
3 |
| 21 |
7718185 | Improved brain delivery and in vitro activity of zidovudine through the use of a redox chemical delivery system. | 1995 Feb |
2 |
| 22 |
8540743 | Antiretroviral activity of stavudine (2',3'-didehydro-3'-deoxythymidine, D4T). | 1995 Jun |
1 |
| 23 |
8564706 | Inhibition of human immunodeficiency virus type 1 multiplication by transforming growth factor beta 1 and AZT in HIV-1-infected myeloid cells. | 1995 Oct |
1 |
| 24 |
8595510 | Zidovudine and lamivudine: results of phase III studies. | 1995 |
1 |
| 25 |
7653284 | Comparative study of various biological markers in infection by HIV1. | 1994 Dec |
1 |
| 26 |
7912084 | Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression. | 1994 Jan |
1 |
| 27 |
7913326 | Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017) | 1994 Mar |
1 |
| 28 |
8067781 | Effect of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine on establishment of human immunodeficiency virus type 1 infection in cultured CD8+ lymphocytes. | 1994 May |
1 |
| 29 |
8086132 | In vitro susceptibility of clinical isolates of HIV-1 to XM323, a non-peptidyl HIV protease inhibitor. | 1994 Jun |
1 |
| 30 |
8089546 | [Investigation of AZT susceptibility of sequential HIV-1 isolates from patients treated with ddI after long-term therapy with AZT]. | 1994 Jul |
2 |
| 31 |
8094279 | Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex. | 1993 Mar 1 |
1 |
| 32 |
8097417 | Zalcitabine. | 1993 Apr |
1 |
| 33 |
8233642 | [Quantitative viremia and p24 antigenemia in short-term follow-up of the treatment with zidovudine in twenty HIV infected patients]. | 1993 Apr |
1 |
| 34 |
8314472 | Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis. | 1993 |
1 |
| 35 |
8471208 | p24 antigenaemia and clinical response to zidovudine therapy. | 1993 Mar |
1 |
| 36 |
1291319 | Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine. | 1992 Dec |
2 |
| 37 |
1322647 | Evaluation of multiple parameters of HIV-1 replication cycle in testing of AIDS drugs in vitro. | 1992 Apr |
1 |
| 38 |
1345755 | Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study. | 1992 Jan 1 |
2 |
| 39 |
1349031 | Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction. | 1992 May |
1 |
| 40 |
1361340 | Detection of circulating p24 antigen-positive CD4+ cells during HIV infection by flow cytometry. | 1992 Oct |
2 |
| 41 |
1418778 | The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex. | 1992 Aug |
2 |
| 42 |
1474134 | A tetrazolium-based colorimetric assay for quantification of HIV-1-induced cytopathogenicity in monocyte-macrophages exposed to macrophage-colony-stimulating factor. | 1992 Dec 1 |
1 |
| 43 |
1567584 | p24 antigenaemia as a predictor of good immunological responsiveness to zidovudine therapy in asymptomatic HIV infection. | 1992 Mar |
1 |
| 44 |
1569343 | Acid dissociation increases the sensitivity of p24 antigen detection for the evaluation of antiviral therapy and disease progression in asymptomatic human immunodeficiency virus-infected persons. | 1992 May |
3 |
| 45 |
1625038 | Modulation of alpha interferon levels by AZT treatment in HIV-seropositive patients. | 1992 |
3 |
| 46 |
1643142 | [Quantification of the levels of p24 antigen and antibodies in human immunodeficiency virus infection]. | 1992 Feb |
1 |
| 47 |
1680791 | The effects of twice and four times daily zidovudine on p24 antigenaemia in CDC stage II/III patients. | 1991 Feb |
3 |
| 48 |
1707962 | In vitro assays show a dissociation of reverse transcriptase activity and core antigen (p24) production in two HIV-1 isolates from a patient receiving long-term treatment with zidovudine (ZDV). | 1991 |
2 |
| 49 |
1709368 | Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. | 1991 May 15 |
1 |
| 50 |
1760231 | Differential alteration of the anti-HIV-1 effect of phosphorothioate oligonucleotide S-dC28 by AZT, interferon-alpha, and dextran sulfate. | 1991 Nov |
1 |